The economic burden of depression with painful symptoms
- PMID: 12755648
The economic burden of depression with painful symptoms
Abstract
The economic burden of depression is substantial. The condition is highly prevalent, with both psychiatric and physical symptoms that often inflict pain. The chronic and often debilitating nature of depression results in costly medical therapies, as well as impaired workplace productivity. As a result, the overall economic burden of depression is comparable to that of serious physical illnesses, such as cancer and heart disease. This article presents an overview of the economic burden of depression and provides background on the relationship between depression and pain in this context. Research findings are also presented on the economic burden associated with a particular manifestation of pain among depressed patients, fibromyalgia. When painful physical symptoms accompany the already debilitating psychiatric and behavioral symptoms of depression, the economic burden that ensues for patients and their employers increases considerably. On purely economic grounds, more aggressive outreach may be warranted for patients with depression and comorbid pain to initiate treatment before symptoms are allowed to persist. However, more research is needed to assess the comprehensive economic impact that depression with painful physical symptoms can have on society.
Similar articles
-
The economic burden of depression in 1990.J Clin Psychiatry. 1993 Nov;54(11):405-18. J Clin Psychiatry. 1993. PMID: 8270583
-
Cost of depression in Europe.J Ment Health Policy Econ. 2006 Jun;9(2):87-98. J Ment Health Policy Econ. 2006. PMID: 17007486
-
Depression: a neglected major illness.J Clin Psychiatry. 1993 Nov;54(11):419-24. J Clin Psychiatry. 1993. PMID: 8270584
-
The societal costs of chronic major depression.J Clin Psychiatry. 2001;62 Suppl 6:5-9. J Clin Psychiatry. 2001. PMID: 11310818 Review.
-
The burden of depression and anxiety in general medicine.J Clin Psychiatry. 2001;62 Suppl 8:4-9; discussion 10-1. J Clin Psychiatry. 2001. PMID: 12108821 Review.
Cited by
-
Macroeconomic fluctuations and individual use of psychotropic medications: evidence from Swedish administrative data.Eur J Public Health. 2023 Feb 3;33(1):93-98. doi: 10.1093/eurpub/ckac182. Eur J Public Health. 2023. PMID: 36622208 Free PMC article.
-
A primary care, multi-disciplinary disease management program for opioid-treated patients with chronic non-cancer pain and a high burden of psychiatric comorbidity.BMC Health Serv Res. 2005 Jan 13;5(1):3. doi: 10.1186/1472-6963-5-3. BMC Health Serv Res. 2005. PMID: 15649331 Free PMC article.
-
Mindfulness-based cognitive therapy (MBCT) versus the health-enhancement program (HEP) for adults with treatment-resistant depression: a randomized control trial study protocol.BMC Complement Altern Med. 2014 Mar 11;14:95. doi: 10.1186/1472-6882-14-95. BMC Complement Altern Med. 2014. PMID: 24612825 Free PMC article. Clinical Trial.
-
[Health-related quality of life (SF-36) in chronic low back pain and comorbid depression].Schmerz. 2010 Jun;24(3):251-6. doi: 10.1007/s00482-010-0923-1. Schmerz. 2010. PMID: 20458502 German.
-
Prevention of Relapse and Recurrence in Adults with Major Depressive Disorder: Systematic Review and Meta-Analyses of Controlled Trials.Int J Neuropsychopharmacol. 2015 Jul 7;19(2):pyv076. doi: 10.1093/ijnp/pyv076. Int J Neuropsychopharmacol. 2015. PMID: 26152228 Free PMC article.
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Medical
Research Materials